10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 223 filers reported holding 10X GENOMICS INC in Q3 2020. The put-call ratio across all filers is 0.25 and the average weighting 1.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $111,540 | -70.5% | 2,704 | -60.0% | 0.00% | -76.9% |
Q2 2023 | $377,590 | +100056.5% | 6,762 | +0.1% | 0.01% | +8.3% |
Q1 2023 | $377 | +255.7% | 6,758 | +132.9% | 0.01% | +200.0% |
Q4 2022 | $106 | -100.0% | 2,902 | -85.0% | 0.00% | -55.6% |
Q3 2022 | $551,000 | -30.1% | 19,347 | +11.2% | 0.01% | -50.0% |
Q2 2022 | $788,000 | +35.2% | 17,398 | +127.2% | 0.02% | +200.0% |
Q1 2022 | $583,000 | -3.2% | 7,657 | +89.7% | 0.01% | -40.0% |
Q4 2021 | $602,000 | +58.4% | 4,037 | +54.4% | 0.01% | 0.0% |
Q3 2021 | $380,000 | -86.4% | 2,615 | -81.7% | 0.01% | -86.3% |
Q2 2021 | $2,795,000 | -1.8% | 14,273 | -9.2% | 0.07% | +52.1% |
Q1 2021 | $2,846,000 | +466.9% | 15,725 | +343.5% | 0.05% | +220.0% |
Q4 2020 | $502,000 | +1631.0% | 3,546 | +1408.9% | 0.02% | – |
Q3 2020 | $29,000 | -63.3% | 235 | -73.4% | 0.00% | -100.0% |
Q2 2020 | $79,000 | -80.3% | 883 | -83.2% | 0.00% | -90.9% |
Q4 2019 | $401,000 | +60.4% | 5,263 | +6.3% | 0.03% | +94.1% |
Q3 2019 | $250,000 | – | 4,952 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Venrock Management VI, LLC | 8,185,565 | $952,538,000 | 99.56% |
Foresite Capital Management I, LLC | 2,750,000 | $342,870,000 | 96.54% |
Foresite Capital Management II, LLC | 3,503,528 | $436,820,000 | 95.05% |
12 West Capital Management LP | 1,922,000 | $239,635,000 | 11.66% |
FINANCIAL CONSULATE, INC | 163,366 | $20,368,000 | 9.67% |
JS Capital Management LLC | 606,400 | $75,606,000 | 3.91% |
Asymmetry Capital Management, L.P. | 43,512 | $5,425,000 | 3.49% |
Pinz Capital Management, LP | 55,400 | $6,907,000 | 2.52% |
HAMILTON LANE ADVISORS LLC | 37,087 | $4,624,000 | 2.24% |
RTW INVESTMENTS, LP | 660,933 | $82,405,000 | 1.98% |